What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original can be viewed in PDF format using the link above.

The text only version may be available from RNIB in large print, Braille or audio CD. For further information call RNIB Medicine Leaflet Line on 0800 198 5000. The product code(s) for this leaflet is: PL 00031/0346.

Konakion MM Paediatric 2 mg/0.2 ml

Patient Information Leaflet

Konakion MM Paediatric 2 mg/0.2 ml

solution for injection or oral administration

Phytomenadione (vitamin K1)

Please read all of this leaflet carefully before your baby or child is given this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask the doctor, nurse or midwife.
  • This medicine has been prescribed for your child. Do not pass it on to others. It may harm them even if their symptoms are the same.
  • If any of the side effects become serious or troublesome, or if you notice any side effects not listed in this leaflet, please tell the doctor, nurse or midwife.

In this leaflet:

1. What Konakion MM Paediatric is and what it is used for
2. Before your baby or child is given Konakion MM Paediatric
3. How Konakion MM Paediatric is given
4. Possible side effects
5. How Konakion MM Paediatric is stored
6. Further information

1. What Konakion MM Paediatric is and what it is used for

Konakion MM Paediatric contains a medicine called phytomenadione. This is a man-made vitamin called vitamin K1. Konakion MM Paediatric is used for the following:

  • Babies who do not have enough vitamin K in their bodies. Giving Konakion MM Paediatric prevents and treats bleeding caused by a lack of vitamin K. This is called ‘vitamin K deficiency bleeding’ (VKDB). This is a serious, but rare condition. All newborn babies are given vitamin K1 with their parent’s permission.
  • Babies and young children who may have had too much of certain medicines to thin their blood (called anticoagulants). Konakion MM Paediatric is normally used to treat these children after advice from a specialist haematologist (blood doctor).

Konakion MM Paediatric works by helping your body make blood clotting factors. These blood clotting factors help stop bleeding.

2. Before your baby or child is given Konakion MM Paediatric

Your child must not be given Konakion MM Paediatric if they are allergic (hypersensitive) to:

  • Phytomenadione or any of the other ingredients of Konakion MM Paediatric (listed in Section 6: Further information).

If you are not sure if this applies to your child, talk to the doctor, nurse or midwife before they are given Konakion MM Paediatric.

Take special care with Konakion MM Paediatric

Check with your doctor, nurse or midwife before your child has Konakion if:

  • They have a problem with the flow of bile in their body (cholestatic disease). Bile is important in helping the body to use some vitamins.

Taking other medicines

Please tell your doctor, nurse or midwife if your child is taking or has recently taken any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Konakion MM Paediatric can affect the way some medicines work. Also some other medicines may affect the way Konakion MM Paediatric works.

In particular, tell your doctor, nurse or midwife if your baby or child is taking medicines to stop their blood clotting (anticoagulants).

Important information about some of the ingredients of Konakion MM Paediatric

Konakion MM Paediatric is essentially ‘sodium free’ as it contains less than 1 millimole sodium (2.64 mg in each millilitre).

3. How Konakion MM Paediatric is given

Konakion MM Paediatric can be given to your child by injection into a vein or muscle or by mouth (orally). How it is given will depend upon what the medicine is being used for and whether your baby was born prematurely. The doctor will decide how much Konakion MM Paediatric your child needs.

Prevention of vitamin K deficiency bleeding

Healthy babies delivered at or nearly full term

These babies will be given either:

  • A single injection (1 mg) either at birth or soon after, or
  • By mouth (oral) a first dose (2 mg) at birth or soon after. This is followed by a second 2 mg dose after 4 to 7 days and third 2 mg dose at 1 month. In exclusively formula fed infants the third oral dose can be omitted.

Premature babies or full term babies at special risk of bleeding

  • These babies will be given Konakion MM Paediatric as an injection at birth or soon after.
  • More injections may be given later if your baby is still at risk of bleeding.

Further doses:

  • Babies who are given vitamin K by mouth and who are breast-fed (not given formula milk) may need more doses of vitamin K by mouth.
  • Bottle-fed babies given the two doses of vitamin K by mouth may not need any more doses of vitamin K. This is because it is included in formula milk.

The instructions ‘How to give your baby Konakion MM Paediatric by mouth’ are given later in this section (section 3).

Treatment of vitamin K deficiency bleeding (VKDB)

  • These babies will be given Konakion MM Paediatric as an injection (usually 1 mg).
  • More injections may be given later if your baby is still at risk of bleeding. Some babies may also need a blood transfusion.

Treatment of too much blood thinning medicine

Treatment of children who have had too much blood thinning medicine is usually decided by a haematologist (blood doctor).

  • Konakion MM Paediatric will be given by injection into one of your child’s veins (IV injection).
  • The doctor will usually check your child’s blood for the levels of clotting factors. This check will be made 2 to 6 hours after giving Konakion MM Paediatric.
  • If your child still does not have enough blood clotting factors, the doctor may give additional doses of Konakion MM Paediatric.

How to give your baby Konakion MM Paediatric by mouth

If your baby was given Konakion MM Paediatric by mouth at birth, you will be asked to give your baby another 2 mg dose. You will give them this by mouth 4 to 7 days after birth.

If your baby is having breast milk and no formula milk you may be asked to give your baby 2 mg doses once a month (by mouth).

The pictures in this leaflet show you how to give the doses to your baby by mouth, using the dispenser provided in the pack. If you are not sure, or have any worries about doing this talk to your health visitor, midwife, doctor or pharmacist.

1. Ampoule and dispenser

2. To open the ampoule

  • Picture 1 shows the ampoule (the small glass container) and the dispenser. The part of the dispenser which can be moved in and out is called the plunger.
  • Shake the ampoule until the liquid is in the bottom of the ampoule. Do not use it if it looks cloudy.
  • Hold the bottom part of the ampoule between the thumb and first finger of one hand. Make sure the spot is facing towards your thumb (see Picture 2).
  • Hold the top of the ampoule between the thumb and first finger of your other hand. Snap the top off by pushing away from the side with the spot (see Picture 2).

3. Put the dispenser into the ampoule. The tip of the dispenser should touch the bottom of the ampoule (see Picture 3). Pull the plunger up slowly to pull the medicine into the dispenser until it is level with the second mark (2 mg) on the side of the dispenser.

The dispenser is designed to draw up the right dose from the ampoule. There may be some liquid left over in the ampoule even after the right dose has been removed. This is OK. Do not give your baby any extra liquid.

4. Put the dispenser into your baby's mouth as shown in Picture 4. Gently push the plunger in, to give your baby the medicine.

If your baby gets more Konakion MM Paediatric than they should

If your baby has had more Konakion MM Paediatric than they should, talk to a doctor, nurse or midwife. The following effects may happen to your baby; jaundice (signs of which are yellowing of the skin or the whites of the eyes), tummy ache, constipation, soft stools (poo), seeming unwell, being agitated (upset), a rash and changes to how well their liver works (shown up by blood tests).

If you forget to give your baby Konakion MM Paediatric

  • If you forget to give your baby their dose of Konakion MM Paediatric by mouth, talk to your health visitor, midwife or doctor about when to give the next dose.
  • Do not give your baby a double dose to make up for a forgotten dose.

If someone else takes your baby’s Konakion MM Paediatric by mistake, they should talk to a doctor.

If you have any further questions on the use of this medicine, ask your doctor, nurse or midwife.

4. Possible side effects

Like all medicines, Konakion MM Paediatric can cause side effects, although not everyone gets them.

The following side effects may happen with this medicine:

Allergic reactions

The signs may include:

  • Swelling of your baby or child’s throat, face, lips and mouth. This may make it difficult for them to breathe or swallow.
  • Sudden swelling of your baby or child’s hands, feet and ankles.

If your baby or child has an allergic reaction, tell a doctor straight away.

A reaction where the injection was given

Rarely this may be severe. Signs include redness, swelling, pain and it may cause a scar.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom

Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard

or search for MHRA Yellow Card in the Google Play or Apple App Store

5. How Konakion MM Paediatric is stored

  • Konakion MM Paediatric ampoules should be stored in their original packaging to protect them from light.
  • Konakion MM Paediatric should be stored at a temperature below 25°C.
  • Keep out of the reach and sight of children.
  • Do not use Konakion MM Paediatric after the expiry date printed on the pack.
  • Do not throw away any whole left over ampoules. Instead, return them to your pharmacist so that they can be disposed of carefully. Only keep them if your doctor tells you to.

6. Further information

What Konakion MM Paediatric contains

The active substance in Konakion MM Paediatric 2 mg/0.2 ml is vitamin K1 (phytomenadione). Each 0.2 ml of liquid medicine contains 2 mg vitamin K1.

Other ingredients are glycocholic acid, sodium hydroxide, lecithin, hydrochloric acid and water for injections.

What Konakion MM Paediatric looks like and contents of the pack

Konakion MM Paediatric is a slightly opalescent, pale yellow liquid (‘solution for injection or oral administration’).

Konakion MM Paediatric is supplied in amber coloured glass ampoules in packs of 5 with plastic oral dispensers.

Marketing Authorisation Holder and Manufacturer

Roche Products Limited
6 Falcon Way
Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom

This leaflet was last revised in February 2018

uk-pl-konakion-clean-180227-2mg-0.2ml-amps